Answer questions and earn CME/CNE Colorectal cancer (CRC) is the third most common
cancer and third leading cause of cancer death in both men and women and second leading …

CRC is the third most commonly diagnosed malignancy and the fourth leading cause of
cancer-related death in the world. With advances in treatment, colorectal cancer is being …

Background Abdominoperineal resection is the standard treatment for patients with distal T2
or T3 rectal cancers; however, the procedure is extensive and mutilating, and alternative …

Background For almost one hundred years abdominoperineal excision has been the
standard treatment of choice for rectal cancer. With advances in the techniques for rectal …

With advances in treatment, colorectal cancer (CRC) is being transformed from a deadly
disease into an illness that is increasingly curable. With this transformation has come …

PURPOSE: There is little knowledge on long-term morbidity after radiotherapy (50 Gy) and
total mesorectal excision for rectal cancer. Therefore, late effects on bowel, anorectal, and …

Purpose Intestinal stomas can pose significant challenges for long-term (≥ 5 years) rectal
cancer (RC) survivors. Specifying common challenges and sociodemographic or clinical …

Background Transanal total mesorectal excision (TaTME) has rapidly become an important
component of the treatment of rectal cancer surgery. Cohort studies have shown feasibility …

Background Colorectal cancer (CRC) is the third most commonly diagnosed cancer in males
and the second in females with a progressive increase in prevalence in industrialized …

Background To determine (i) the prevalence of sexual (dys) function in patients with
colorectal cancer and (ii) treatment-related and sociodemographic aspects in relation to …